The treatment of rectal cancer with synchronous liver metastases: A matter of strategy

被引:4
|
作者
Gelsomino, Fabio [1 ]
Spallanzani, Andrea [1 ]
Garajova, Ingrid [2 ]
机构
[1] Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, Italy
[2] Univ Hosp Parma, Med Oncol Unit, Via Gramsci 14, I-43126 Parma, Italy
关键词
Rectal cancer; Liver metastases; Neoadjuvant treatment; Chemotherapy; Radiotherapy; SHORT-COURSE RADIOTHERAPY; WILD-TYPE KRAS; COLORECTAL-CANCER; PHASE-II; OPEN-LABEL; COURSE CHEMORADIATION; NEOADJUVANT TREATMENT; 1ST-LINE TREATMENT; RANDOMIZED-TRIAL; CHEMOTHERAPY;
D O I
10.1016/j.critrevonc.2019.05.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Around one fifth of patients with rectal cancer (RC) have synchronous metastatic disease at the diagnosis. The optimal treatment sequence for patients with RC and synchronous liver metastases (LM) is complex and unclear, missing strong, evidence-based recommendations. From a clinical point of view, this situation is highly heterogeneous and the treatment strategy is generally determined by a number of factors, such as the potential resectability of primary tumor and LM, patients' characteristics, the presence of primary tumor-related symptoms and the response to therapies. Treatment options for these patients include systemic therapy, short-course radiotherapy (SC-RT), long-course chemoradiotherapy (LC-CRT) and surgery of the primary tumor and LM. The principal goal is to render the patients eligible to radical surgery, thus offering a chance of cure at least for some of them. This review summarizes the most appropriate treatment strategies which should be recommended in the different clinical scenarios of this heterogeneous condition.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 50 条
  • [1] Rectal cancer with synchronous liver metastases
    Koeberle, D.
    [J]. ONKOLOGIE, 2011, 34 : 4 - 4
  • [2] How to manage a rectal cancer with synchronous liver metastases? A question of strategy
    Vendrely, V.
    Terlizzi, M.
    Huguet, F.
    Denost, Q.
    Chiche, L.
    Smith, D.
    Bachet, J. -B.
    [J]. CANCER RADIOTHERAPIE, 2017, 21 (6-7): : 539 - 543
  • [3] Treatment of rectal cancer patients with synchronous liver metastases.
    Privalov, Alexey
    Antonov, Andrey
    Vazenin, Andrey
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Managing synchronous rectal cancer and liver metastases
    Kuhlmann, Koert
    Fisher, Simon G.
    Poston, Graeme
    [J]. COLORECTAL CANCER, 2015, 4 (03) : 115 - 118
  • [5] The preliminary experience in simultaneous treatment of rectal cancer and synchronous liver metastases with laparoscopy
    Zhu, Ziman
    Tan, Jing-Wang
    Tan, Hua-Min
    Hu, Ben-Shun
    Chen, Ke
    Ding, Xiang-Min
    Leng, Jian-Jun
    Chen, Fei
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2013, 24 (02): : 127 - 133
  • [6] Synchronous liver metastases in rectal cancer, which treatment modality has priority?
    De Wilt, J. H. W.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : I22 - I22
  • [7] Multimodal treatment of rectal cancer with resectable synchronous liver metastases: A systematic review
    Colletti, Gaia
    Ciniselli, Chiara Maura
    Sorrentino, Luca
    Bagatin, Clara
    Verderio, Paolo
    Cosimelli, Maurizio
    [J]. DIGESTIVE AND LIVER DISEASE, 2023, 55 (12) : 1602 - 1610
  • [8] Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases
    Benoist, S
    Pautrat, K
    Mitry, E
    Rougier, P
    Penna, C
    Nordlinger, B
    [J]. BRITISH JOURNAL OF SURGERY, 2005, 92 (09) : 1155 - 1160
  • [9] Impact of the strategy for curative treatment of synchronous colorectal cancer liver metastases
    Raoux, L.
    Maulat, C.
    Mokrane, F. -Z.
    Fares, N.
    Suc, B.
    Muscari, F.
    [J]. JOURNAL OF VISCERAL SURGERY, 2020, 157 (04) : 289 - 299
  • [10] RECTAL CANCER WITH SYNCHRONOUS RESECTABLE METASTASES: WHICH IS THE BEST STRATEGY?
    Bachet, J.
    Ksiaa, M.
    Declety, G.
    Mitry, E.
    Lepere, C.
    Benoist, S.
    Vaillant, J.
    Housset, M.
    Penna, C.
    Nordlinger, B.
    Rougier, P.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 21 - 22